• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

托珠单抗治疗干扰素 α 和抗肿瘤坏死因子-α 治疗失败的鸟枪弹样脉络膜视网膜炎:两例报告及文献复习。

Tocilizumab for the treatment of birdshot uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy: two cases report and literature review.

机构信息

Normandie Université UNI Rouen, Service de Médecine Interne, CHU Charles Nicolle, 76000, Rouen, France.

Normandie Université UNI Rouen U1096, Service de Médecine Interne, CHU Charles Nicolle, 76000, Rouen, France.

出版信息

Clin Rheumatol. 2018 Mar;37(3):849-853. doi: 10.1007/s10067-018-4007-4. Epub 2018 Feb 3.

DOI:10.1007/s10067-018-4007-4
PMID:29397459
Abstract

Biotherapies appear as potential drugs for the treatment of inflammatory noninfectious uveitis. In this report, we show that tocilizumab, an anti-IL-6 agent, greatly improved two patients with birdshot chorioretinopathy refractory to conventional immunosuppressive drugs, interferon α2a, and anti-TNFα agents. After a follow-up of 22 months, patients exhibited an improvement of both visual acuity and macular edema. A corticosteroid-sparing effect was achieved in both cases.

摘要

生物疗法似乎是治疗炎症性非传染性葡萄膜炎的潜在药物。在本报告中,我们表明,托珠单抗(一种抗 IL-6 药物)极大地改善了两名对常规免疫抑制药物、干扰素 α2a 和抗 TNFα 药物难治的鸟枪弹样脉络膜视网膜病变患者的病情。随访 22 个月后,患者的视力和黄斑水肿均得到改善。两种情况下均实现了皮质类固醇的节省效应。

相似文献

1
Tocilizumab for the treatment of birdshot uveitis that failed interferon alpha and anti-tumor necrosis factor-alpha therapy: two cases report and literature review.托珠单抗治疗干扰素 α 和抗肿瘤坏死因子-α 治疗失败的鸟枪弹样脉络膜视网膜炎:两例报告及文献复习。
Clin Rheumatol. 2018 Mar;37(3):849-853. doi: 10.1007/s10067-018-4007-4. Epub 2018 Feb 3.
2
Efficacy of Anti-IL6-Receptor Tocilizumab in Refractory Cystoid Macular Edema of Birdshot Retinochoroidopathy Report of Two Cases and Literature Review.抗白介素 6 受体托珠单抗治疗鸟枪弹样脉络膜视网膜病变难治性囊样黄斑水肿的疗效:两例报告及文献复习。
Ocul Immunol Inflamm. 2017 Oct;25(5):604-609. doi: 10.1080/09273948.2016.1231331. Epub 2016 Oct 11.
3
Anti-TNF-α agents for refractory cystoid macular edema associated with noninfectious uveitis.用于治疗与非感染性葡萄膜炎相关的难治性黄斑囊样水肿的抗TNF-α制剂
Graefes Arch Clin Exp Ophthalmol. 2014 Apr;252(4):633-40. doi: 10.1007/s00417-013-2552-8. Epub 2013 Dec 24.
4
Long-term effects of tocilizumab therapy for refractory uveitis-related macular edema.托珠单抗治疗难治性葡萄膜炎相关黄斑水肿的长期疗效。
Ophthalmology. 2014 Dec;121(12):2380-6. doi: 10.1016/j.ophtha.2014.06.050. Epub 2014 Sep 6.
5
Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients.抗白细胞介素 6 受体托珠单抗治疗难治性非感染性葡萄膜炎相关的囊样黄斑水肿:25 例患者的多中心研究。
Am J Ophthalmol. 2019 Apr;200:85-94. doi: 10.1016/j.ajo.2018.12.019. Epub 2019 Jan 17.
6
Anti-Tumor Necrosis Factor α versus Tocilizumab in the Treatment of Refractory Uveitic Macular Edema: A Multicenter Study from the French Uveitis Network.抗肿瘤坏死因子α与托珠单抗治疗难治性葡萄膜炎性黄斑水肿的疗效比较:来自法国葡萄膜炎网络的多中心研究
Ophthalmology. 2022 May;129(5):520-529. doi: 10.1016/j.ophtha.2021.11.013. Epub 2021 Nov 16.
7
Tocilizumab treatment for refractory uveitis-related cystoid macular edema.托珠单抗治疗难治性葡萄膜炎相关的囊样黄斑水肿。
Graefes Arch Clin Exp Ophthalmol. 2013 Nov;251(11):2627-32. doi: 10.1007/s00417-013-2436-y. Epub 2013 Jul 27.
8
Efficacy of tocilizumab in two patients with anti-TNF-alpha refractory uveitis.托珠单抗治疗两例抗 TNF-α 药物难治性葡萄膜炎的疗效。
Ocul Immunol Inflamm. 2011 Oct;19(5):382-3. doi: 10.3109/09273948.2011.606593.
9
Adalimumab in refractory cystoid macular edema associated with birdshot chorioretinopathy.阿达木单抗治疗与鸟枪弹样脉络膜视网膜病变相关的难治性黄斑囊样水肿
Int Ophthalmol. 2018 Jun;38(3):1357-1362. doi: 10.1007/s10792-017-0592-5. Epub 2017 Jun 12.
10
IL-6 blockade in the management of non-infectious uveitis.白细胞介素-6阻断剂在非感染性葡萄膜炎治疗中的应用
Clin Rheumatol. 2017 Jul;36(7):1459-1469. doi: 10.1007/s10067-017-3672-z. Epub 2017 May 20.

引用本文的文献

1
Tocilizumab attenuates choroidal neovascularization by regulating macrophage polarization through the IL-6R/STAT3/VEGF pathway.托珠单抗通过IL-6R/STAT3/VEGF途径调节巨噬细胞极化来减轻脉络膜新生血管形成。
Heliyon. 2024 Mar 14;10(6):e27893. doi: 10.1016/j.heliyon.2024.e27893. eCollection 2024 Mar 30.
2
Birdshot Chorioretinopathy in Early Adulthood: Review of Current Literature and Case Report.青年期鸟枪弹样脉络膜视网膜病变:当前文献综述及病例报告
Int Med Case Rep J. 2023 Dec 11;16:815-831. doi: 10.2147/IMCRJ.S430981. eCollection 2023.
3
Perspectives of Therapeutic Drug Monitoring of Biological Agents in Non-Infectious Uveitis Treatment: A Review.

本文引用的文献

1
Primary (Month-6) Outcomes of the STOP-Uveitis Study: Evaluating the Safety, Tolerability, and Efficacy of Tocilizumab in Patients With Noninfectious Uveitis.STOP-葡萄膜炎研究的主要(第6个月)结局:评估托珠单抗在非感染性葡萄膜炎患者中的安全性、耐受性和疗效。
Am J Ophthalmol. 2017 Nov;183:71-80. doi: 10.1016/j.ajo.2017.08.019. Epub 2017 Sep 5.
2
IL-6 blockade in the management of non-infectious uveitis.白细胞介素-6阻断剂在非感染性葡萄膜炎治疗中的应用
Clin Rheumatol. 2017 Jul;36(7):1459-1469. doi: 10.1007/s10067-017-3672-z. Epub 2017 May 20.
3
TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA.
非感染性葡萄膜炎治疗中生物制剂治疗药物监测的展望:综述
Pharmaceutics. 2023 Feb 25;15(3):766. doi: 10.3390/pharmaceutics15030766.
4
Efficacy and safety of abatacept to treat active birdshot uveitis: a prospective open label interventional proof-of-concept trial.阿巴西普治疗活动性鸟枪弹样脉络膜视网膜炎的疗效和安全性:一项前瞻性开放标签干预性概念验证试验。
Br J Ophthalmol. 2024 Jan 29;108(2):244-252. doi: 10.1136/bjo-2022-321585.
5
Pathogenesis and current therapies for non-infectious uveitis.非感染性葡萄膜炎的发病机制和当前治疗方法。
Clin Exp Med. 2023 Aug;23(4):1089-1106. doi: 10.1007/s10238-022-00954-6. Epub 2022 Nov 24.
6
SARS-CoV-2 vaccination and uveitis: Are they linked?新型冠状病毒2型疫苗接种与葡萄膜炎:它们有关联吗?
Ann Med Surg (Lond). 2022 Sep;81:104472. doi: 10.1016/j.amsu.2022.104472. Epub 2022 Aug 28.
7
Birdshot Chorioretinopathy: A Review.鸟枪弹样脉络膜视网膜病变:综述
J Clin Med. 2022 Aug 16;11(16):4772. doi: 10.3390/jcm11164772.
8
Mechanisms, Pathophysiology and Current Immunomodulatory/Immunosuppressive Therapy of Non-Infectious and/or Immune-Mediated Choroiditis.非感染性和/或免疫介导性脉络膜炎的发病机制、病理生理学及当前免疫调节/免疫抑制治疗
Pharmaceuticals (Basel). 2022 Mar 24;15(4):398. doi: 10.3390/ph15040398.
9
HLA-A29 Birdshot Retinochoroiditis in Its 5th Decade: Selected Glimpses into the Intellectual Meanderings and Progresses in the Knowledge of a Long-Time Misunderstood Disease.HLA - A29相关鸟枪弹样视网膜脉络膜炎进入第五个十年:对一种长期被误解疾病认知中的思维曲折与进展的若干瞥见
Diagnostics (Basel). 2021 Jul 19;11(7):1291. doi: 10.3390/diagnostics11071291.
10
Biotherapies in Uveitis.葡萄膜炎的生物疗法
J Clin Med. 2020 Nov 8;9(11):3599. doi: 10.3390/jcm9113599.
托西珠单抗治疗难治性葡萄膜炎相关黄斑水肿的 24 个月随访结果。
Retina. 2018 Jul;38(7):1361-1370. doi: 10.1097/IAE.0000000000001690.
4
Interferon-alpha2a and Systemic Corticosteroid in Monotherapy in Chronic Uveitis: Results of the Randomized Controlled BIRDFERON Study.干扰素α2a与全身用皮质类固醇单药治疗慢性葡萄膜炎:随机对照BIRDFERON研究结果
Am J Ophthalmol. 2017 May;177:182-194. doi: 10.1016/j.ajo.2017.03.001. Epub 2017 Mar 14.
5
Efficacy of Anti-IL6-Receptor Tocilizumab in Refractory Cystoid Macular Edema of Birdshot Retinochoroidopathy Report of Two Cases and Literature Review.抗白介素 6 受体托珠单抗治疗鸟枪弹样脉络膜视网膜病变难治性囊样黄斑水肿的疗效:两例报告及文献复习。
Ocul Immunol Inflamm. 2017 Oct;25(5):604-609. doi: 10.1080/09273948.2016.1231331. Epub 2016 Oct 11.
6
Adalimumab in Patients with Active Noninfectious Uveitis.阿达木单抗治疗活动性非感染性葡萄膜炎患者的疗效。
N Engl J Med. 2016 Sep 8;375(10):932-43. doi: 10.1056/NEJMoa1509852.
7
Birdshot chorioretinopathy: current knowledge and new concepts in pathophysiology, diagnosis, monitoring and treatment.鸟枪弹样脉络膜视网膜病变:病理生理学、诊断、监测及治疗方面的当前认知与新概念
Orphanet J Rare Dis. 2016 May 12;11(1):61. doi: 10.1186/s13023-016-0429-8.
8
Outcome of tocilizumab treatment in refractory ocular inflammatory diseases.托珠单抗治疗难治性眼部炎性疾病的疗效
Acta Ophthalmol. 2016 Sep;94(6):e400-6. doi: 10.1111/aos.13015. Epub 2016 Mar 24.
9
Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial.托珠单抗诱导和维持巨细胞动脉炎缓解的疗效:一项 2 期、随机、双盲、安慰剂对照试验。
Lancet. 2016 May 7;387(10031):1921-7. doi: 10.1016/S0140-6736(16)00560-2. Epub 2016 Mar 4.
10
Autoimmune uveitis: clinical, pathogenetic, and therapeutic features.自身免疫性葡萄膜炎:临床、发病机制及治疗特点
Clin Exp Med. 2016 May;16(2):125-36. doi: 10.1007/s10238-015-0345-6. Epub 2015 Mar 28.